Stock EGTX EGETIS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Egetis Therapeutics AB

Equities

EGTX

SE0003815604

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:34 26/04/2024 BST 		5-day change 1st Jan Change
5.75 SEK -3.20% Intraday chart for Egetis Therapeutics AB -9.73% +3.05%
02-22 Egetis Therapeutics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
02-22 Egetis Therapeutics AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Egetis Therapeutics AB

Price target over the last 5 years

History of analyst recommendation changes

f8ad3ad885b71b98be.0YX1J_OCrvc5darOA5_NGsiooXnQmXfBW4b8Kg1YSKs.5sHDEZL63KZjIp20e6qET4KQ4C65rhyIGdy5Wl4QMoa19J5Li-b4gkAGwQ~7029fcf7928ab1a23f91ea669497bd6f

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.75 SEK
Average target price
13.12 SEK
Spread / Average Target
+128.26%
High Price Target
17.5 SEK
Spread / Highest target
+204.35%
Low Price Target
11 SEK
Spread / Lowest Target
+91.30%

Consensus detail

Consensus revision (last 18 months)

Ratings for Egetis Therapeutics AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EGTX Stock
  4. Consensus Egetis Therapeutics AB